Review on iron regulatory hormone Hepcidin
DOI:
https://doi.org/10.61841/rarj8t21Keywords:
Hepcidin, Hormones, Metabolism, AnemiaAbstract
To study a review on the iron-regulating hormone hepcidin. Hepcidin is a major regulator of iron metabolism. This review is done on hepcidin and its role in the regulation of iron in our body. Hepcidin is a 25-amino acid peptide that is synthesized in hepatocytes. Liver-derived hepcidin peptide is secreted in response to iron and inflammation and interacts with the iron export protein ferroprotein. Hepcidin can control both the total body iron by modulating intestinal iron absorption as well as promote iron available for erythropoiesis by affecting the efficiency with which macrophages recycle iron from red blood cells. This review will give information about the hormone hepcidin and the regulation of iron in the human body.
Downloads
References
1. Ganz T. Molecular Control of Iron Transport. Journal of the American Society of Nephrology
2007;18:394–400. https://doi.org/10.1681/asn.2006070802.
2. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc HematolEduc
Program 2006: 2006:29–35, 507.
3. Zaritsky J, Young B, Gales B, Wang H-J, Rastogi A, Westerman M, et al. Reduction of serum hepcidin by
hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol 2010;5:1010–4.
4. VujicSpasic M, Kiss J, Herrmann T, Kessler R, Stolte J, Galy B, et al. Physiological systemic iron
metabolism in mice deficient for duodenal Hfe. Blood 2007;109:4511–7.
5. Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J
Nutr2008;138:2284–8.
6. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular
iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090–3.
7. Casanovas G, Swinkels DW, Altamura S, Schwarz K, Laarakkers CM, Gross H-J, et al. Growth
differentiation factor 15 in patients with congenital dyserythropoietic anemia (CDA) type II. J Mol Med
2011;89:811–6.
8. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, et al. Antihepcidin antibody treatment
modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood
2010;115:3616–24.
9. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the
liver. J Biol Chem 2001;276:7806–10.
10. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly
disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147–50.
11. Kemna EHJM, E H J, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential
diagnosis. Haematologica 2008;93:90–7. https://doi.org/10.3324/haematol.11705.
12. Kroot JJC, Kemna EHJM, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first
international round robin for the quantification of urinary and plasma hepcidin assays: need for
standardization. Haematologica Haematologica2009;94:1748–52.
13. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, et al. Liver iron concentrations and urinary
hepcidin in beta-thalassemia. Haematologica 2007; 92:583–8.
14. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of
anemia of inflammation is a type II acute-phase protein. Blood 2003;101:2461–3.
15. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, et al. Increased adipose tissue expression of
Hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788–96.
16. Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, et al. Pharmacologic inhibition of
Hepcidin expression reverses anemia of chronic inflammation in rats. Blood 2011;118:4977–84.
17. Core AB, Canali S, Babitt JL. Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron
Homeostasis. Frontiers in Pharmacology 2014;5. https://doi.org/10.3389/fphar.2014.00104.
18. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron
The regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest
2002;110:1037–44.
19. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum
iron and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864–6.
20. Corradini E, Schmidt PJ, Meynard D, Garuti C, Montosi G, Chen S, et al. BMP6 treatment compensates for
the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. Gastroenterology
2010;139:1721–9.
21. Gulec S, Anderson GJ, Collins JF. Mechanistic and regulatory aspects of intestinal iron absorption.
American Journal of Physiology-Gastrointestinal and Liver Physiology 2014;307:G397–409.
https://doi.org/10.1152/ajpgi.00348.2013.
22. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009;75:976–81.
23. Uchiyama Y, Yorozu K, Hashizume M, Moriya Y, Mihara M. Tocilizumab, a Humanized Anti-interleukin-
6 Receptor Antibody Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis. Biol
Pharm Bull 2008;31:1159–63.
24. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, et al. STAT3 Is Required for IL-6-
gp130–Dependent Activation of Hepcidin In Vivo. Gastroenterology 2007;132:294–300.
25. Verga Falzacappa MV, Vujic-Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3
mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007;109:353–8.
26. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum
using liquid chromatography tandem mass spectrometry. Blood 2007;110:1048–54.
27. Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, et al. Development of a method for the sensitive
and quantitative determination of hepcidin in human serum using LC-MS/MS. J PharmacolToxicol
Methods 2009;59:171–80.
28. Bansal SS, Halket JM, Fusova J, Bomford A, Simpson RJ, Vasavda N, et al. Quantification of hepcidin
using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Communications
in Mass Spectrometry: An International Journal Devoted to the Rapid Dissemination of Up-to-the-Minute
Research in Mass Spectrometry 2009;23:1531–42.
29. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology
2010; 139: 393–408, 408.e1–2.
30. Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, et al. In anemia of multiple myeloma,
Hepcidin is induced by increased bone morphogenetic protein 2. Blood 2010;116:3635–44.
31. Busbridge M, Griffiths C, Ashby D, Gale D, Jayantha A, Sanwaiya A, et al. Development of a novel
immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009;66:150–7.
32. Elliott J, Mishler D, Agarwal R. Hyporesponsiveness to erythropoietin: causes and management. Adv
Chronic Kidney Dis 2009;16:94–100.
33. Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, et al. Hepcidin as a therapeutic tool to
limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest 2010;120:4466–77.
34. Kroot JJC, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650–69.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
